Pharmacodynamic and pharmacokinetic investigation of cyclodextrin-mediated asenapine maleate in situ nasal gel for improved bioavailability

References

• Citrome L. Asenapine review, part I: chemistry, receptor affinity profile, pharmacokinetics and metabolism. Expert Opin Drug Metab Toxicol 2014;10:893–903.
   PubMed Web of Science ®Google Scholar
• Avachat A, Kapure S. Asenapine maleate in situ forming biodegradable implant: an approach to enhance bioavailability. Int J Pharm 2014;477:64–72.
   PubMed Web of Science ®Google Scholar
• Lisbeth I. Nasal drug delivery: new developments and strategies. Drug Discov Today 2002;7:1184–9.
   Google Scholar
• Priyanka A, Shringi S, Sanjay G. Permeability issues in nasal drug delivery. Drug Discov Today 2002;7:967–75.
   Google Scholar
• Illum L. 2003. Nasal drug delivery – possibilities, problems and solutions. J Control Release 2003;87:187–98.
   PubMed Web of Science ®Google Scholar
• Pardeshi CV, Belgamwar VS. Direct nose to brain drug delivery via integrated nerve pathways bypassing the blood-brain barrier: an excellent platform for brain targeting. Expert Opin Drug Deliv 2013;10:957–72.
   PubMed Web of Science ®Google Scholar
• Wu H, Hu K, Jiang X. From nose to brain: understanding transport capacity and transport rate of drugs. Expert Opin Drug Deliv 2000;5:1159–68.
   Web of Science ®Google Scholar
• Dhuria SV, Hanson LR, Frey WH. Intranasal delivery to the central nervous system: mechanisms and experimental considerations. J Pharm Sci 2010;99:1654–73.
   PubMed Web of Science ®Google Scholar
• Hussein A. Intranasal drug delivery. Adv Drug Deliv Rev 1998;29:39–49.
   PubMed Web of Science ®Google Scholar
• Zhou M, Donovan M. Intranasal mucociliary clearance of putative bioadhesive polymer gels. Int J Pharm 1996;135:115–25.
   Web of Science ®Google Scholar
• Ugwoke MI, Verbeke N, Kinget R, et al. Scintigraphic evaluation in rabbits of nasal drug delivery systems based on carbopol 971p((R)) and carboxymethylcellulose. J Control Release 2000;68:207–14.
   PubMed Web of Science ®Google Scholar
• Bertram U, Bodmeier R. In situ gelling, bioadhesive nasal inserts for extended drug delivery: In vitro characterization of a new nasal dosage form. Eur J Pharm Sci 2006;27:62–71.
   PubMed Web of Science ®Google Scholar
• Kurti L, Gaspar R, Marki A, et al. In vitro and in vivo characterization of meloxicam nanoparticles designed for nasal administration. Eur J Pharm Sci 2013;50:86–92.
   PubMed Web of Science ®Google Scholar
• Singh R, Kumar A, Pathak K. Mucoadhesive in situ nasal gelling drug delivery systems for modulated drug delivery. Expert Opin Drug Deliv 2013;10:115–30.
   PubMed Web of Science ®Google Scholar
• Hosny KM, Banjar ZM. The formulation of a nasal nanoemulsion zaleplon in situ gel for the treatment of insomnia. Expert Opin Drug Deliv 2013;10:1033–41.
   PubMed Web of Science ®Google Scholar
• Ravi PR, Adityaa N, Patil S, Cherian L. Nasal in-situ gels for delivery of rasagiline mesylate: improvement in bioavailability and brain localization. Drug Deliv 2015;22:903–10.
   PubMed Web of Science ®Google Scholar
• Kaur P, Garg T, Vaidya B, et al. Brain delivery of intranasal in situ gel of nano-particulated polymeric carriers containing antidepressant drug: behavioral and biochemical assessment. J Drug Target 2015;23:275–86.
   PubMed Web of Science ®Google Scholar
• Wang S, Chen P, Zhang L, et al. Formulation and evaluation of microemulsion-based in situ ion-sensitive gelling systems for intranasal administration of curcumin. J Drug Target 2012;20:831–40.
   PubMed Web of Science ®Google Scholar
• Bandwalkar M, Avachat A. Thermoreversible nasal in situ gel of venlafaxine hydrochloride: formulation, characterization, and pharmacodynamic evaluation. AAPS Pharm SciTech 2013;14:101–10.
   PubMed Web of Science ®Google Scholar
• Chung TW, Liu DZ, Yang JS. Effects of interpenetration of thermo-sensitive gels by crosslinking of chitosan on nasal delivery of insulin: in vitro characterization and in vivo study. Carbohydr Polym 2010;82:316–22.
   Web of Science ®Google Scholar
• Bramhankar DM, Jaiswal SB. Biopharmaceutics and pharmacokinetics a treatise, absorption of drugs. 2nd edn. New Delhi, India: Vallabhprakashan; 2005:9–92.
   Google Scholar
• Jabbal GJ, Fishera AN, Hinchcliffea M, et al. Cyclodextrins as protection agents against enhancer damage in nasal delivery systems II. Effect on in vivo absorption of insulin and histopathology of nasal membrane. Eur J Pharm Sci 1994;1:237–48.
   Web of Science ®Google Scholar
• Singh RM, Kumar A, Pathak K. Thermally triggered mucoadhesive in situ gel of loratadine: ?-cyclodextrin complex for nasal delivery. AAPS PharmSciTech 2013;14:412–24.
   PubMed Web of Science ®Google Scholar
• Merkus FWHM, Schipper NGM, Hermens WAJJ, Romeijn SG, Verhoef JC. Absorption enhancers in nasal drug delivery: efficacy and safety. J Control Release 1993;24:201–8.
   Web of Science ®Google Scholar
• Zhang Y, Ren K, He Z, et al. Development of inclusion complex of brinzolamide with hydroxypropyl-β-cyclodextrin. Carbohydr Polym 2013;98:638–43.
   PubMed Web of Science ®Google Scholar
• Sarah G, Robert CS. 2-Hydroxypropyl-β-cyclodextrin (HP-β-CD): a toxicology review. Food Chem Toxicol 2005;43:1451–9.
   PubMed Web of Science ®Google Scholar
• Terekhova IV, Scriba G. Study on complex formation of biologically active pyridine derivatives with cyclodextrins by capillary electrophoresis. J Pharm Biomed Anal 2007;45:688–93.
   PubMed Web of Science ®Google Scholar
• Zakia N, Awada G, Mortada N, AbdEl Hadyb SS. Enhanced bioavailability of metoclopramide HCl by intranasal administration of a mucoadhesive in situ gel with modulated rheological and mucociliary transport properties. Eur J Pharm Sci 2007;32:296–307.
   PubMed Web of Science ®Google Scholar
• Higuchi T, Connors K. Phase solubility techniques. Adv Anal Chem Instrum 1965;4:117–212.
   Google Scholar
• Dandawate P, Vyas A, Ahmad A, et al. Inclusion complex of novel curcumin analog CDF and β cyclodextrin (1:2) and its enhanced in vivo anticancer activity against pancreatic cancer. Pharm Res 2012;29:1775–86.
   PubMed Web of Science ®Google Scholar
• Schmolka IR. Artificial skin. I. Preparation and properties of pluronic F-127 gels for treatment of burns. J Biomed Mater Res 1972;6:571–82.
   PubMed Web of Science ®Google Scholar
• Dumortier G, Grosslord JL, Agnely F, Chaumeil JC. A review of poloxamer 407 pharmaceutical and pharmacological characteristics. Pharm Res 2006;23:2709–27.
   PubMed Web of Science ®Google Scholar
• Choi HG, Oh YK, Kim CK. In situ gelling and mucoadhesive liquid suppository containing acetaminophen: enhanced bioavailability. Int J Pharm 1998;165:23–32.
   Web of Science ®Google Scholar
• Yong CS, Choi JS, Quan QZ, et al. Effect of sodium chloride on the gelation temperature, gel strength and bioadhesive force of poloxamer gels containing diclofenac sodium. Int J Pharm 2001;226:195–205.
   PubMed Web of Science ®Google Scholar
• Jones DS, Woolfson AD, Brown AF, et al. Design characterization and preliminary clinical evaluation of a novel mucoadhesive topical formulation containing tetracycline for the treatment of periodontal disease. J Control Release 2000;67:357–68.
   PubMed Web of Science ®Google Scholar
• Chng HS, Park H, Kelly P, Robinson JR. Bioadhesive polymers as platforms for oral controlled drug delivery II. Synthesis and evaluation of some swelling water-insoluble bioadhesive polymers. J Pharm Sci 1985;74:339–405.
   Web of Science ®Google Scholar
• Becker A. Ketamine-induced changes in rat behaviour: A possible animal model of schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2003;27:687–700.
   PubMed Web of Science ®Google Scholar
• Gavini E, Rassu G, Ferraro L, et al. Influence of polymeric micro carriers on the in vivo intranasal uptake of an anti-migraine drug for brain targeting. Eur J Pharm Biopharm 2013;83:74–183.
   Web of Science ®Google Scholar
• Wu H, Liang H, Yuan Q, et al. Preparation and stability investigation of the inclusion complex of sulforaphane with hydroxy propyl-beta-cyclodextrin. Carbohydr Polym 2010;82:613–17.
   Web of Science ®Google Scholar
• Patel A, Shah P, Shah P, Shah S. Formulation development and evaluation of thermoreversible mucoadhesive in situ nasal gel of asenapine maleate. Curr Psycho Pharmacol 2014;3:203–18.
   Google Scholar
• Loukas Y, Vraka V, Gregoriadis G. Novel non-acidic formulations of haloperidol complexed with beta-cyclodextrin derivatives. J Pharm Biomed Anal 1997;16:263–8.
   PubMed Web of Science ®Google Scholar
• Gratieri T, Gelfuso GM, Rocha ER, et al. A poloxamer/chitosan in situ forming gel with prolonged retention time for ocular delivery. Eur J Pharm Biopharm 2010;75:186–93.
   PubMed Web of Science ®Google Scholar
• Bonacucina G, Spina M, Misici-Falzi M, et al. Effect of hydroxypropyl beta-cyclodextrin on the self-assembling and thermogelation properties of poloxamer 407. Eur J Pharm Sci 2007;32:115–22.
   PubMed Web of Science ®Google Scholar
• Hilton JE, Summers MP. The effect of wetting agents on the dissolution of indomethacin solid dispersion systems. Int J Pharm 1986;31:157–61.
   Web of Science ®Google Scholar